《大行報告》大和升思摩爾(06969.HK)評級至「買入」 目標價上調至24元
大和發表報告,在過去一周中國和美國發布有關電子煙監管公告後,思摩爾(06969.HK)的收入能見度略有改善,將其評級由「跑贏大市」上調至「買入」,目標價由21元上調至24元。
大和認為,思摩爾大多數負面因素已經被市場反映,而且公司從本月7日開始回購股票,目前的買入價吸引。該行認為,中國監管最大積極因素是電子煙監管規例提供5個月的過渡期,這將在今年9月30日之前繼續銷售有味電子煙,作為最大和最先進的製造商,認為思摩爾很可能在今年6月獲得中國銷售許可證。
在美國,一家聯邦法院命令FDA從本月29日開始每90天提供一份煙草上市前審查(PMTA)進度報告,這應該會讓FDA在做出PMTA決定時更加緊迫,包括思摩爾最重要的產品Vuse Alto的決定。根據尼爾森的數據,大和預計針對Vuse Alto的決定將成為FDA的首要任務,因為它在今年第一季在美國的市場份額已是最高。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.